Creyon Bio Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $40M
Latest Deal Amount
  • Investors
  • 5

Creyon Bio General Information

Description

Developer of drugs designed to engineer RNA-based medicines and their components. The company creates proprietary, purpose-built datasets that inform powerful machine learning models, rapidly identifying the design rules and engineering principles for safe and effective OBMs (Oligonucleotide-based medicines), helping the healthcare sector to save costs for new medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 3210 Merryfield Row
  • San Diego, CA 92121
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Creyon Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 08-Mar-2022 $40M 0000 Completed Stealth
1. Early Stage VC Completed Stealth
To view Creyon Bio’s complete valuation and funding history, request access »

Creyon Bio Patents

Creyon Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210319851-A1 Oligonucleotide-based machine learning Pending 03-Apr-2020 000000000

Creyon Bio Executive Team (4)

Name Title Board Seat Contact Info
Christopher Hart Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Nathan Billings Ph.D Chief Strategy Officer
Monica McArthur Ph.D Chief Technology Officer
Swagatam Mukhopadhyay Ph.D Co-Founder , Chief Scientific Officer & Board Member
To view Creyon Bio’s complete executive team members history, request access »

Creyon Bio Board Members (4)

Name Representing Role Since
Dennis Langer MD Self Board Member 000 0000
Kiersten Stead Ph.D DCVC Bio Board Member 000 0000
Swagatam Mukhopadhyay Ph.D Creyon Bio Co-Founder , Chief Scientific Officer & Board Member 000 0000
Zavain Dar Lux Capital Board Member 000 0000
To view Creyon Bio’s complete board members history, request access »

Creyon Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
Biobrit Venture Capital Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
DCVC Bio Venture Capital Minority 000 0000 000000 0
Lux Capital Venture Capital Minority 000 0000 000000 0
To view Creyon Bio’s complete investors history, request access »